Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Jenscare Scientific Co's Enterprise Value is HK$535.72 Mil.
Jenscare Scientific Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-414.49 Mil. Therefore, Jenscare Scientific Co's EV-to-EBIT ratio for today is -1.29.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Jenscare Scientific Co's Enterprise Value is HK$535.72 Mil.
Jenscare Scientific Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-401.30 Mil. Therefore, Jenscare Scientific Co's EV-to-EBITDA ratio for today is -1.33.
Jenscare Scientific Co Enterprise Value Historical Data
The historical data trend for Jenscare Scientific Co's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Jenscare Scientific Co's Enterprise Value
For the Medical Devices subindustry, Jenscare Scientific Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jenscare Scientific Co's Enterprise Value Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Jenscare Scientific Co's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Jenscare Scientific Co's Enterprise Value falls into.
Jenscare Scientific Co Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Jenscare Scientific Co's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jenscare Scientific Co (HKSE:09877) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Jenscare Scientific Co's current Enterprise Value is HK$535.72 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Jenscare Scientific Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-414.49 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Jenscare Scientific Co's EV-to-EBITDA for today is:
Jenscare Scientific Co's current Enterprise Value is HK$535.72 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Jenscare Scientific Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-401.30 Mil.
Jenscare Scientific Co's current Enterprise Value is HK$535.72 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Jenscare Scientific Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jenscare Scientific Co Enterprise Value Related Terms
Thank you for viewing the detailed overview of Jenscare Scientific Co's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Jenscare Scientific Co (HKSE:09877) Business Description
Jenscare Scientific Co Ltd is a China-based company mainly engaged in the manufacturing and research and development of medical devices. The company develops interventional products for the treatment of structural heart disease. The company's core products include LuX-Valve and Ken-Valve. LuX-Valve is a transcatheter tricuspid valve replacement system designed for patients with severe tricuspid regurgitation and high surgical risk. Ken-Valve is designed for the treatment of severe aortic regurgitation or combined with aortic stenosis. The company also develops product candidates for the treatment of mitral valve diseases and medical devices for the treatment of heart failure.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:09877 has been successfully added to your